FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3176514303> ?p ?o ?g. }

• W3176514303 endingPage "923" @default.
• W3176514303 startingPage "915" @default.
• W3176514303 abstract "BACKGROUND: For multiple sclerosis (MS) patients taking disease-modifying therapies (DMTs), adherence to treatment is a key component of achieving beneficial outcomes, such as delayed disease progression and the reduction and prevention of symptoms and relapses. OBJECTIVES: The aim of this study was to assess the impact of a claims-based measure of MS disease severity on DMT adherence in a one-year study period. METHODS: Patients were identified from Humana Medicare Advantage claims data from January 1, 2013 to December 31, 2015. Patients over the age of 18 with at least 12 months of continuous enrollment and > 1 outpatient MS visit with DMT use prior to the index date were included. Patients who switched DMT type (oral, platform, IV) during the study period were excluded. Medication possession ratios (MPR) for DMTs were calculated from pharmacy and medical claims over 12 months of claims data, and a previously developed claims algorithm was used to determine MS disease severity. Patients with MPRs of 0.8 or higher were considered adherent to DMT treatment. Multivariable logistic regression was used to evaluate the association of MS disease severity, gender, DMT type, and age category with DMT adherence. RESULTS: The study population of 3,347 patients had an average MPR of 84.7 (75% were classified as adherent). Multivariable logistic analysis demonstrated that compared to the 18-45 age group, the 46-64 and 65+ age groups were 1.33 (OR: 1.33 [95% CI 1.08-1.64]) and 1.55 (OR: 1.55, [95% CI 1.18-2.05]) times more likely to be adherent. Patients with a high level of MS disease severity were 53% (OR: 0.47, [95% CI 0.36-0.62]) less likely to be adherent compared to those with low MS disease severity. No significant difference was identified for gender or DMT type (oral, platform, or IV). CONCLUSIONS: Increased age and lower MS disease severity were associated with better DMT adherence. MS disease severity should be considered when assessing risk for low DMT adherence. DISCLOSURES: No funding supported this project. The authors have nothing to disclose. Preliminary results were previously presented virtually at AMCP Annual 2020 in April 2020." @default.
• W3176514303 created "2021-07-05" @default.
• W3176514303 creator A5037714580 @default.
• W3176514303 creator A5063967006 @default.
• W3176514303 creator A5073724616 @default.
• W3176514303 date "2021-07-01" @default.
• W3176514303 modified "2023-09-23" @default.
• W3176514303 title "Association between multiple sclerosis disease severity and adherence to disease-modifying therapies" @default.
• W3176514303 cites W114705015 @default.
• W3176514303 cites W147698845 @default.
• W3176514303 cites W1908756607 @default.
• W3176514303 cites W1982508920 @default.
• W3176514303 cites W1984705645 @default.
• W3176514303 cites W2014094373 @default.
• W3176514303 cites W2018445432 @default.
• W3176514303 cites W2024127533 @default.
• W3176514303 cites W2053121650 @default.
• W3176514303 cites W2058555284 @default.
• W3176514303 cites W2061166054 @default.
• W3176514303 cites W2064816281 @default.
• W3176514303 cites W2075112416 @default.
• W3176514303 cites W2080458330 @default.
• W3176514303 cites W2087206336 @default.
• W3176514303 cites W2127183200 @default.
• W3176514303 cites W2133755641 @default.
• W3176514303 cites W2137665561 @default.
• W3176514303 cites W2139367012 @default.
• W3176514303 cites W2147982456 @default.
• W3176514303 cites W2169098250 @default.
• W3176514303 cites W2493463222 @default.
• W3176514303 cites W2555603121 @default.
• W3176514303 cites W2560929962 @default.
• W3176514303 cites W2608396028 @default.
• W3176514303 cites W2753714268 @default.
• W3176514303 cites W2800924304 @default.
• W3176514303 cites W2888620891 @default.
• W3176514303 cites W2897332214 @default.
• W3176514303 cites W2903513024 @default.
• W3176514303 cites W2915068397 @default.
• W3176514303 cites W2979910979 @default.
• W3176514303 cites W2993910655 @default.
• W3176514303 cites W2993960054 @default.
• W3176514303 cites W3031559624 @default.
• W3176514303 cites W3036363204 @default.
• W3176514303 cites W3090222429 @default.
• W3176514303 cites W3095682907 @default.
• W3176514303 cites W3118589378 @default.
• W3176514303 cites W33609267 @default.
• W3176514303 cites W4297966720 @default.
• W3176514303 cites W2944190721 @default.
• W3176514303 doi "https://doi.org/10.18553/jmcp.2021.27.7.915" @default.
• W3176514303 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34185555" @default.
• W3176514303 hasPublicationYear "2021" @default.
• W3176514303 type Work @default.
• W3176514303 sameAs 3176514303 @default.
• W3176514303 citedByCount "3" @default.
• W3176514303 countsByYear W31765143032022 @default.
• W3176514303 countsByYear W31765143032023 @default.
• W3176514303 crossrefType "journal-article" @default.
• W3176514303 hasAuthorship W3176514303A5037714580 @default.
• W3176514303 hasAuthorship W3176514303A5063967006 @default.
• W3176514303 hasAuthorship W3176514303A5073724616 @default.
• W3176514303 hasConcept C104863432 @default.
• W3176514303 hasConcept C126322002 @default.
• W3176514303 hasConcept C151956035 @default.
• W3176514303 hasConcept C203014093 @default.
• W3176514303 hasConcept C2779134260 @default.
• W3176514303 hasConcept C2780640218 @default.
• W3176514303 hasConcept C2908647359 @default.
• W3176514303 hasConcept C512399662 @default.
• W3176514303 hasConcept C71924100 @default.
• W3176514303 hasConcept C99454951 @default.
• W3176514303 hasConceptScore W3176514303C104863432 @default.
• W3176514303 hasConceptScore W3176514303C126322002 @default.
• W3176514303 hasConceptScore W3176514303C151956035 @default.
• W3176514303 hasConceptScore W3176514303C203014093 @default.
• W3176514303 hasConceptScore W3176514303C2779134260 @default.
• W3176514303 hasConceptScore W3176514303C2780640218 @default.
• W3176514303 hasConceptScore W3176514303C2908647359 @default.
• W3176514303 hasConceptScore W3176514303C512399662 @default.
• W3176514303 hasConceptScore W3176514303C71924100 @default.
• W3176514303 hasConceptScore W3176514303C99454951 @default.
• W3176514303 hasIssue "7" @default.
• W3176514303 hasLocation W31765143031 @default.
• W3176514303 hasLocation W31765143032 @default.
• W3176514303 hasOpenAccess W3176514303 @default.
• W3176514303 hasPrimaryLocation W31765143031 @default.
• W3176514303 hasRelatedWork W2034669414 @default.
• W3176514303 hasRelatedWork W2088377755 @default.
• W3176514303 hasRelatedWork W2388217304 @default.
• W3176514303 hasRelatedWork W2389709268 @default.
• W3176514303 hasRelatedWork W2625825622 @default.
• W3176514303 hasRelatedWork W2997255441 @default.
• W3176514303 hasRelatedWork W3094917185 @default.
• W3176514303 hasRelatedWork W3211075891 @default.
• W3176514303 hasRelatedWork W4308866213 @default.
• W3176514303 hasRelatedWork W2478153090 @default.
• W3176514303 hasVolume "27" @default.

• next